Scrip
Novavax shares slide on cash injection
25 November 2009
Christopher Spillane
Please Login to read the full article.
25 November 2009
Christopher Spillane
christopher.spillane@informausa.com
Novavax's share price has tumbled by more than 15% in the days following the pricing of its public offering.
The vaccine developer raised net proceeds of around $21 million to fund preclinical and clinical trials of its virus-like-particle (VLP) technology as well as other research programmes...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
FEATURES
- Connexios: Harnessing the Indian cost advantage in network biology
- Roche's Asian partnering head looks to tap regional innovation
EVENTS
01 January 1970
London, UK
01 January 1970
San Diego, US
01 January 1970
Providence, Rhode Island, and San Francisco, California
JOB OF THE WEEK
Promote your vacancy here
